Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 50 announcements

Share price: ₹2,496.30
Market cap: ₹1,03,108 Cr
Revenue (annual): ₹14,278 Cr
Net profit (annual): ₹1,913 Cr
P/E (TTM): 50.5×Sector 47.4×
Promoter holding: 72.63%-0.03% QoQ
FII holding: 9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 10 Employee Stock Options 6 Annual General Meeting 5 Other Announcement 4 Management Change 4 Earnings Call 4 Financial Results 3 Debt & Borrowing 3 Results Update 2 Credit Rating 2 Board Meeting Date 2 Share Pledge 1 Partnership 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

12 May 2026 18:18 IST BSE

Credit Rating

Mankind Pharma Credit Rating

ICRA reaffirmed Mankind Pharma's AA+ ratings and assigned A1+ for ₹6,850 Crore in debt instruments. The stable outlook reflects the company's robust credit profile.

Value: ₹6,850 Cr

Read the filing ↗

22 Apr 2026 20:18 IST BSE

Credit Rating

Mankind Pharma Credit Rating

Mankind Pharma Limited has been assigned credit ratings by CARE Ratings Limited for ₹1,000 Crore in bank facilities. The long-term and short-term facilities received 'CARE AA+; Stable' and 'CARE A1+' ratings respectively. This assignment reflects the company's creditworthiness and stable financial outlook.

Value: ₹1,000 Cr

Read the filing ↗